Bausch Health
BHC
$9.77
Share price
-7.28%
Change (1 day)
-42.85%
Change (1 year)
Categories
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.
Earnings for Bausch Health (BHC)
Earnings in 2024 (TTM): NZ$0.30 Billion
According to Bausch Health 's latest financial reports the company's current earnings are NZ$9.62 Billion. . The earnings displayed on this page is the company's Pretax Income.
Earnings history for Bausch Health from 1994 to 2024
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2024  | NZ$0.28 B | |
| 2022 | -NZ$0.23 Billion | -87.4% |
| 2021 | -NZ$1.77 Billion | 9.64% |
| 2020 | -NZ$1.62 Billion | -49.16% |
| 2019 | -NZ$3.17 Billion | -55.78% |
| 2018 | -NZ$7.17 Billion | 138.6% |
| 2017 | -NZ$3.01 Billion | -28.5% |
| 2016 | -NZ$4.2 Billion | 1806.89% |
| 2015 | -NZ$0.23 Billion | -111.69% |
| 2014 | NZ$1.88 B | -183.12% |
| 2013 | -NZ$2.27 Billion | 233.41% |
| 2012 | -NZ$0.68 Billion | 2090.16% |
| 2011 | -NZ$31.04 Million | -92.38% |
| 2010 | -NZ$0.41 Billion | -235.04% |
| 2009 | NZ$0.30 B | 37.86% |
| 2008 | NZ$0.21 B | -39.2% |
| 2007 | NZ$0.35 B | -174.56% |
| 2006 | -NZ$0.49 Billion | -331.49% |
| 2005 | NZ$0.20 B | 92.86% |
| 2004 | NZ$0.10 B | -254.51% |
| 2003 | -NZ$69.97 Million | -137.13% |
| 2002 | NZ$0.18 B | 6.39% |
| 2001 | NZ$0.17 B | -240.25% |
| 2000 | -NZ$0.13 Billion | -1229.21% |
| 1999 | NZ$11.18 M | -86.29% |
| 1998 | NZ$81.54 M | 27.15% |
| 1997 | NZ$64.12 M | 59.23% |
| 1996 | NZ$40.27 M | -1329.6% |
| 1995 | -NZ$3.28 Million | 850% |
| 1994 | -NZ$0.35 Million |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 | -NZ$31.3 Million | -110.87% | 🇺🇸 USA |
 | -NZ$17.87 Million | -106.21% | 🇺🇸 USA |